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Introduction
Spinal muscular atrophy (SMA) is an autosomal recessive, 
neurodegenerative disease that affects infants. It results from 
the loss of function of the Survival Motor Neuron 1 (SMN1) 
gene. Survival Motor Neuron 2 (SMN2), a nearly identical 
copy of SMN1, fails to compensate for the loss of SMN1 due 
to predominant skipping of exon 7 during pre-mRNA splicing 
(Prior, 2008). This skipping of SMN2 exon 7 results in a 
shortened mRNA that makes an unstable, truncated protein. 
Currently, researchers aim to develop therapeutic strategies 
that will correct SMN2 exon 7 splicing. However, successful 
strategies cannot be developed until the mechanism of 
SMN2 pre-mRNA splicing is fully understood. Thus, in this 
study I screened for novel cis-acting regulatory elements that 
modify and control the splicing of SMN2 pre-mRNA to test 
the following hypothesis: if there remain critical unknown cis-
elements that regulate the splicing of SMN2 pre-mRNA, then 
by finding these elements we can gain a better 
understanding of the mechanism behind SMN2 pre-mRNA 
splicing (Figure 1). 
Results
As shown in Figure 4 lane 4, mutant ∆426-435 showed the 
greatest inclusion. The other two mutants shown in lane 2 
and 3 exhibited little inclusion similar to wild type in lane 5. 
Lanes 6 and 7 show previously generated mutants (Singh et 
al., 2013). Branch point is deleted in mutant ∆421-440 (lane 
7); thus, no splicing occurs. Lane 8 is a negative control, no 
plasmid was used during transfection. 
Conclusion
From these results, we propose that, due to the deletion in 
mutant ∆426-435, an alternative branch point in intron 7 was 
used during pre-mRNA splicing. This novel branch point shift 
results in more inclusion of exon 7 in the final spliced 
products. Overall, a novel RNA area that appears to have 
regulatory activity in splicing of SMN2 was found. Further 
characterization of this area is needed. 
References
Pagani, F., & Baralle, F. E. (2004). Genomic variants in exons and introns: identifying the splicing 
spoilers. Nat. Rev. Genet., 5, 389-396.  
Prior, T. W. (2008). Carrier screening for spinal muscular atrophy. Genetics in Medicine, 10(11), 
840-842. 
Promega Corporation. (2009). pCI and pSI Mammalian Expression Vectors: Instructions for use of 
products E1721 and E1731. Madison, WI: Promega Corporation. 
Singh, N. N., Androphy, E. J., & Singh, R .N. (2004). An extended inhibitory context causes 
skipping of exon 7 of SMN2 in spinal muscular atrophy. Biochem. Biophys. Res. 
Commun., 325, 381-388.
Singh, N. N., Lawler, M. N., Ottesen E. W., Upreti, D., Kaczynski, J. R., & Singh, R. N. (2013). An 
intronic structure enabled by a long-distance interaction serves as a novel target for 
splicing correction in spinal muscular atrophy. Nucleic Acids Res, 41(17), 8144-8165.
Materials and Methods
Within a reporter system previously established (Singh et al., 
2004), called a “minigene”, that contains SMN2 DNA from 
exon 6 to exon 8 (introns included), I created three different 
10bp deletions within intron 7 to see their effect on SMN2
pre-mRNA splicing (Figure 2).
I. Construction of Mutated Minigene
I. 2-Step Polymerase Chain Reaction (Figure 3)
II. Restriction Digestion
III. Ligation and Transformation
II. Transfection
III. RNA Extraction, Reverse Transcription, and Polymerase 
Chain Reaction
IV. Gel Electrophoresis 
Figure 2. Overlapping deletions in SMN2 intron 7. Nucleotide numbering starts at the 
beginning of intron 7. Deleted nucleotides are shown as dashed lines. Mutation names 
on the left correspond to the deleted region of intron 7. 
Figure 1. Schematic diagram of minigene derived SMN2 pre-mRNA splicing. The top 
splicing pattern is that of exon 7 exclusion and the bottom splicing pattern is that of exon 
7 inclusion.
Figure 4. Visual 
representation of mutant 
minigene splicing patterns. 
Gel lanes are numbered 
sequentially. Molecular ladder 
bands are numbered on the 
left. Mutant names are labeled 
across the top. Ex7(+) is 
pointing to the top band where 
exon 7 is included and Ex7(-) 
is pointing to the bottom band 
where exon 7 is not included. 
Figure 3. Schematic diagram of 2-step PCR templates and primers. Fragment 1 and 2 
for each 10bp deletion were generated in the first PCR step with the primers shown. 
These fragments were then ligated together in the second PCR step (shown below the 
middle arrow) to generate a single fragment using the primers shown. 
